Special topic pages

• Complying with advertising rules for therapeutic goods when making an ASX announcement

  31 October 2024

  Guidance

  This guidance will assist companies making announcements, to comply with their continuous disclosure obligations, without advertising therapeutic goods to the public.

• Complying with advertising requirements when naming therapeutic goods

  17 October 2024

  Guidance

  The trade name of a therapeutic good must comply with therapeutic goods legislation, including advertising legislation.

• Using 'natural' claims in therapeutic goods advertising

  18 October 2024

  Guidance

  Guidance about how you can use terms such as 'natural' without misleading consumers.

Advertising specific products and services

• Advertising personalised medical devices in Australia

  23 September 2024

  Guidance

  Guidance on understanding the rules for advertising therapeutic goods to consumers

• Advertising medicinal cannabis products is prohibited

  23 September 2024

  Guidance

  If your business is involved with medicinal cannabis products or health services involving medicinal cannabis, this guidance will help ensure you do not unlawfully advertise medicinal cannabis to consumers. This includes through the promotion of your business or services.

• Advertising guidance for providers of disease education activities

  Reference material

  Complying with therapeutic goods advertising restrictions.

• Advertising prescription medicine Ozempic (semaglutide) is prohibited

  Page

  Ozempic is a prescription only medicine and cannot be advertised to the public.

• Determining if your product is a cosmetic or therapeutic good

  9 October 2024

  Guidance

  This guidance will assist you in determining if a product is a cosmetic or a therapeutic good and how to comply with Australian regulatory requirements and advertising rules for therapeutic goods.

• Advertising a health service

  23 September 2024

  Guidance

  Guidance on advertising services that involve therapeutic goods.

• Advertising health services and cosmetic injections: frequently asked questions and answers

  Page

  Find out answers to frequently asked questions about advertising cosmetic injection services and our guidelines.

• Advertising codeine to the general public is prohibited

  Page

  Information for sponsors and advertisers about advertising codeine.

• Advertising stem cell and other human cell or tissue (HCT) products

  23 September 2024

  Guidance

  Guidance about how to promote your business and service, without advertising biologicals to the public.

• Advertising mushroom products that are therapeutic goods

  17 October 2024

  Guidance

  Guidance on complying with therapeutic goods advertising requirements.

• Advertising medicinal cannabis products is prohibited

  23 September 2024

  Guidance

  If your business is involved with medicinal cannabis products or health services involving medicinal cannabis, this guidance will help ensure you do not unlawfully advertise medicinal cannabis to consumers. This includes through the promotion of your business or services.

• Advertising intravenous (IV) drip therapies

  23 September 2024

  Guidance

  This guidance assists providers of IV drips to understand how to comply with the therapeutic goods advertising requirements in Australia.

• Importing or supplying sport supplements

  2 October 2024

  Guidance

  Guidance about the regulation of sport supplements in Australia for importers and sellers.

Advertising to health professionals

• Advertising to health professionals so that consumer rules do not apply

  17 October 2024

  Guidance

  Guidance about how to advertise therapeutic goods exclusively to health professionals.

Social media advertising

• Advertising therapeutic goods on social media

  23 September 2024

  Guidance

  This guidance aims to help advertisers apply the legislative requirements for advertising therapeutic goods on social media platforms.

• Advertising: Sample social media acceptable use policy

  31 May 2022

  Reference material

  We have published a social media acceptable use policy that advertisers can use on their digital platforms.